BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33683930)

  • 1. Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission.
    Paltiel AD; Zheng A; Sax PE
    Ann Intern Med; 2021 Jun; 174(6):803-810. PubMed ID: 33683930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Economic Impact of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission.
    Paltiel AD; Zheng A; Sax PE
    medRxiv; 2021 Feb; ():. PubMed ID: 33564779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. College Campuses and COVID-19 Mitigation: Clinical and Economic Value.
    Losina E; Leifer V; Millham L; Panella C; Hyle EP; Mohareb AM; Neilan AM; Ciaranello AL; Kazemian P; Freedberg KA
    Ann Intern Med; 2021 Apr; 174(4):472-483. PubMed ID: 33347322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study.
    Du Z; Pandey A; Bai Y; Fitzpatrick MC; Chinazzi M; Pastore Y Piontti A; Lachmann M; Vespignani A; Cowling BJ; Galvani AP; Meyers LA
    Lancet Public Health; 2021 Mar; 6(3):e184-e191. PubMed ID: 33549196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States.
    Paltiel AD; Zheng A; Walensky RP
    JAMA Netw Open; 2020 Jul; 3(7):e2016818. PubMed ID: 32735339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs.
    Campbell JR; Uppal A; Oxlade O; Fregonese F; Bastos ML; Lan Z; Law S; Oh CE; Russell WA; Sulis G; Winters N; Yanes-Lane M; Brisson M; Laszlo S; Evans TG; Menzies D
    CMAJ; 2020 Oct; 192(40):E1146-E1155. PubMed ID: 32907820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 Pandemic.
    Baggett TP; Scott JA; Le MH; Shebl FM; Panella C; Losina E; Flanagan C; Gaeta JM; Neilan A; Hyle EP; Mohareb A; Reddy KP; Siedner MJ; Harling G; Weinstein MC; Ciaranello A; Kazemian P; Freedberg KA
    JAMA Netw Open; 2020 Dec; 3(12):e2028195. PubMed ID: 33351082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated Transmission Outcomes and Costs of SARS-CoV-2 Diagnostic Testing, Screening, and Surveillance Strategies Among a Simulated Population of Primary School Students.
    Bilinski A; Ciaranello A; Fitzpatrick MC; Giardina J; Shah M; Salomon JA; Kendall EA
    JAMA Pediatr; 2022 Jul; 176(7):679-689. PubMed ID: 35442396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.
    Sandmann FG; Davies NG; Vassall A; Edmunds WJ; Jit M;
    Lancet Infect Dis; 2021 Jul; 21(7):962-974. PubMed ID: 33743846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    COVID-19 Cumulative Infection Collaborators
    Lancet; 2022 Jun; 399(10344):2351-2380. PubMed ID: 35405084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing and isolation strategies in nursing homes.
    Bartsch SM; Weatherwax C; Martinez MF; Chin KL; Wasserman MR; Singh RD; Heneghan JL; Gussin GM; Scannell SA; White C; Leff B; Huang SS; Lee BY
    Infect Control Hosp Epidemiol; 2024 Jun; 45(6):754-761. PubMed ID: 38356377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Strategies to Reduce COVID-19 Mortality in Nursing Homes.
    Dong S; Jutkowitz E; Giardina J; Bilinski A
    JAMA Health Forum; 2024 Apr; 5(4):e240688. PubMed ID: 38669030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa.
    Walensky RP; Borre ED; Bekker LG; Resch SC; Hyle EP; Wood R; Weinstein MC; Ciaranello AL; Freedberg KA; Paltiel AD
    Ann Intern Med; 2016 Sep; 165(5):325-33. PubMed ID: 27240120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring the COVID-19 Mortality Burden in the United States : A Microsimulation Study.
    Reif J; Heun-Johnson H; Tysinger B; Lakdawalla D
    Ann Intern Med; 2021 Dec; 174(12):1700-1709. PubMed ID: 34543588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of mask mandates on subways to prevent SARS-CoV-2 transmission in the United States.
    Park J; Joo H; Kim D; Mase S; Christensen D; Maskery BA
    PLoS One; 2024; 19(5):e0302199. PubMed ID: 38748706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic.
    Pulia MS; O'Brien TP; Hou PC; Schuman A; Sambursky R
    Ann Med; 2020 Aug; 52(5):207-214. PubMed ID: 32370561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying optimal COVID-19 testing strategies for schools and businesses: Balancing testing frequency, individual test technology, and cost.
    Lyng GD; Sheils NE; Kennedy CJ; Griffin DO; Berke EM
    PLoS One; 2021; 16(3):e0248783. PubMed ID: 33764982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of Hepatitis C by Screening and Treatment in U.S. Prisons.
    He T; Li K; Roberts MS; Spaulding AC; Ayer T; Grefenstette JJ; Chhatwal J
    Ann Intern Med; 2016 Jan; 164(2):84-92. PubMed ID: 26595252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.